Results 181 to 190 of about 37,478 (219)
Some of the next articles are maybe not open access.
The American Journal of the Medical Sciences, 1997
Benign prostatic hyperplasia is a common and costly disease that affects older men. This article reviews the underlying histopathologic changes that cause benign prostatic hyperplasia. The symptoms and systematic evaluation of the patient are described, along with the current therapeutic options for treatment.
openaire +2 more sources
Benign prostatic hyperplasia is a common and costly disease that affects older men. This article reviews the underlying histopathologic changes that cause benign prostatic hyperplasia. The symptoms and systematic evaluation of the patient are described, along with the current therapeutic options for treatment.
openaire +2 more sources
BENIGN PROSTATIC HYPERPLASIA (THE AGING PROSTATE)
Medical Clinics of North America, 1999BPH is a common phenomenon of the aging process. Clinical manifestations may range from minimally bothersome symptoms to urinary retention and renal failure. Tailoring of treatment based on the individual patient is required for successful management. For mild symptoms, watchful waiting is a valid option.
J J, Medina, R O, Parra, R G, Moore
openaire +2 more sources
CHRONIC PROSTATITIS IN BENIGN PROSTATIC HYPERPLASIA
British Journal of Urology, 1971SUMMARY Gross and histological studies of surgically resected prostate glands and glands recovered at autopsy have shown a close correlation between the type of hyperplasia in the gland and the degree of chronic prostatitis. Three types of hyperplasia are recognised.
E O, Odunjo, E A, Elebute
openaire +2 more sources
MANAGEMENT OF BENIGN PROSTATIC HYPERPLASIA
Annual Review of Medicine, 1997▪ Abstract Benign prostatic hyperplasia (BPH) is a common cause of morbidity among older men. Primary care physicians need to develop expertise in its management. The causes of BPH are unknown; aging and the presence of male androgens are the dominant risk factors.
M, Barry, C, Roehrborn
openaire +2 more sources
Medicina Clínica (English Edition)
Benign prostatic hyperplasia (BPH) is a histopathologic definition associated with enlargement of the prostate gland that causes obstruction of the lower urinary tract and manifests clinically with characteristic symptoms that are what bring patients for consultation.
Sarelis, Infante Hernández +2 more
openaire +2 more sources
Benign prostatic hyperplasia (BPH) is a histopathologic definition associated with enlargement of the prostate gland that causes obstruction of the lower urinary tract and manifests clinically with characteristic symptoms that are what bring patients for consultation.
Sarelis, Infante Hernández +2 more
openaire +2 more sources
Terazosin for benign prostatic hyperplasia
Cochrane Database of Systematic Reviews, 2000Lower urinary tract symptoms associated with benign prostatic obstruction (BPO) occur in up to 70% of men over the age of 60 years. To relieve these bothersome symptoms, treatment options include alpha-antagonists, also know as alpha-blockers.We conducted a systematic review to evaluate the effectiveness and adverse effects of the alpha-blocker ...
T J, Wilt +3 more
openaire +2 more sources
Primary Care: Clinics in Office Practice, 2019
Benign prostatic hyperplasia (BPH) is a common condition in aging men that is frequently associated with troublesome lower urinary tract symptoms (LUTS). The American Urologic Association Symptom Index is a validated, self-administered tool that is used to diagnose LUTS, guide initial treatment, and assess treatment response.
openaire +2 more sources
Benign prostatic hyperplasia (BPH) is a common condition in aging men that is frequently associated with troublesome lower urinary tract symptoms (LUTS). The American Urologic Association Symptom Index is a validated, self-administered tool that is used to diagnose LUTS, guide initial treatment, and assess treatment response.
openaire +2 more sources
Clinics in Geriatric Medicine, 2010
This article reviews the epidemiology of benign prostatic hyperplasia (BPH), evaluation of patients with lower urinary tract symptomatology (LUTS), and management of patients with BPH and LUTS. The evaluation includes history and physical examination, laboratory testing, and specialized studies.
openaire +2 more sources
This article reviews the epidemiology of benign prostatic hyperplasia (BPH), evaluation of patients with lower urinary tract symptomatology (LUTS), and management of patients with BPH and LUTS. The evaluation includes history and physical examination, laboratory testing, and specialized studies.
openaire +2 more sources
Phytotherapy for Benign Prostatic Hyperplasia
Current Urology Reports, 2016The use of complementary and alternative medications for symptomatic benign prostatic hyperplasia is a lucrative business in the USA with revenues reaching close to US$6.4 billion in sales for the 2014 fiscal year. Yet, despite its popularity, the evidence supporting the continued use of phytotherapy for symptomatic benign prostatic hyperplasia (BPH ...
Aryeh, Keehn +2 more
openaire +2 more sources
Nocturia and benign prostatic hyperplasia
Urology, 2003To examine the frequency of and risk factors for nocturia in patients with symptomatic benign prostatic hyperplasia (BPH), and the degree of improvement of nocturia after treatment for BPH.A total of 505 consecutively selected, newly diagnosed patients with symptomatic BPH were evaluated in studies examining frequency of and risk factors for nocturia ...
Koji, Yoshimura +6 more
openaire +2 more sources

